Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mezzopram 40mg dispersible gastro-resistant tab (NorthStar)
0103050P0BGAFAP
|
Mezzopram | Omeprazole | Gastro-Intestinal System | No data available |
|
Mil-Par liquid
0106040J0BDAAAF
|
Mil-Par | Magnesium hydroxide | Gastro-Intestinal System | No data available |
|
Molative Paediatric oral powder 6.9g sachets
0106040M0BIABAB
|
Molative | Macrogol 3350 | Gastro-Intestinal System | No data available |
|
Nalcrom 100mg capsules (Imported(Canada))
0105040A0BBABAA
|
Nalcrom | Sodium cromoglicate | Gastro-Intestinal System | No data available |
|
Neo Baby Gripe mixture
0101012A0BEAAA0
|
Neo Gripe | Gripe mixtures | Gastro-Intestinal System | No data available |
|
Nexium 20mg gastro-resistant tablets (Arrow)
0103050E0BBAEAA
|
Nexium | Esomeprazole | Gastro-Intestinal System | No data available |
|
Nexium 40mg gastro-resistant tablets (Arrow)
0103050E0BBAFAB
|
Nexium | Esomeprazole | Gastro-Intestinal System | No data available |
|
Nexium I.V 40mg powder for solution for injection vials
0103050E0BBACAC
|
Nexium | Esomeprazole | Gastro-Intestinal System | No data available |
|
Nifedipine 2% ointment
0107040B0AAAAAA
|
Nifedipine (Anal) | Nifedipine | Gastro-Intestinal System | No data available |
|
Nizatidine 100mg/4ml solution for infusion ampoules
0103010N0AAACAC
|
Nizatidine | Nizatidine | Gastro-Intestinal System | No data available |
|
Nizatidine 150mg/5ml oral liquid
0103010N0AAADAD
|
Nizatidine | Nizatidine | Gastro-Intestinal System | No data available |
|
Normaloe 2mg tablets
0104020L0BJAAAD
|
Normaloe | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Normax capsules
0106020J0BBAAAA
|
Normax | Co-danthrusate (Dantron/docusate sodium) | Gastro-Intestinal System | No data available |
|
Normax oral suspension
0106020J0BBABAD
|
Normax | Co-danthrusate (Dantron/docusate sodium) | Gastro-Intestinal System | No data available |
|
Nortase capsules
010904000BBADA0
|
Proprietary compound preparation BNF 0109040 | Other pancreatin preparations | Gastro-Intestinal System | No data available |
|
Numark Constipation Relief 5mg gastro-resistant tablets
0106020C0BIAAAA
|
Numark (Bisacodyl) | Bisacodyl | Gastro-Intestinal System | No data available |
|
Numark Diarrhoea Relief 2mg capsules
0104020L0BTAAAA
|
Numark (Loperamide) | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Numark Diarrhoea Relief Instants 2mg orodispersible tablets
0104020L0BTABAR
|
Numark (Loperamide) | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Numark Epsom Salts
0106040L0BCAAAB
|
Numark (Magesium sulfate) | Magnesium sulfate | Gastro-Intestinal System | No data available |
|
Numark Mebeverine 135mg tablets
0102000P0BJAAAB
|
Numark (Mebeverine hydrochloride) | Mebeverine hydrochloride | Gastro-Intestinal System | No data available |
|
Numark Sodium bicarbonate powder
0101012B0BHAAAP
|
Numark (Sodium bicarbonate) | Sodium bicarbonate | Gastro-Intestinal System | No data available |
|
Nupercainal 1.1% ointment
0107010G0BBAAAA
|
Nupercainal | Cinchocaine hydrochloride | Gastro-Intestinal System | No data available |
|
Nurse Harveys Gripe mixture
0101012B0BEAABX
|
Nurse Harveys Gripe | Sodium bicarbonate | Gastro-Intestinal System | No data available |
|
Nutrizym 10 gastro-resistant capsules
0109040N0BEADAT
|
Nutrizym | Pancreatin | Gastro-Intestinal System | No data available |
|
Nutrizym GR modified-release capsules
0109040N0BEABAK
|
Nutrizym | Pancreatin | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.